The evidence base for non-CF bronchiectasis is finally evolving

Respirology

Volumn 19, Issue 3, 2014, Pages 295-297

  Serisier, David J ^a,b  

^a MATER ADULT HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

azithromycin; bacterial drug resistance; bronchiectasis; erythromycin; macrolide

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; DEOXYRIBONUCLEASE; ERYTHROMYCIN; MACROLIDE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ATYPICAL MYCOBACTERIUM; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; CYSTIC FIBROSIS;

ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CYSTIC FIBROSIS; HUMANS; MACROLIDES;

EID: 84896268994     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12247     Document Type: Editorial

References (13)

1. Wu Q, Shen W, Cheng H, Zhou X,. Long-term macrolides for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Respirology 2014; 19: 321-329.
2. Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380: 660-667.
3. O'Donnell AE, Barker AF, Ilowite JS, Fick RB,. Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase 1. Chest 1998; 113: 1329-1334.
4. Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahn SA, Smith LJ, Stewart JO, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 481-485.
5. Barker A, O'Donnell AE, Thompson PJ, Flume P, Ruzi J, de Gracia J, Boersma W, Polverino E, Shao L, Zhang J, et al. Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-CF bronchiectasis (NCFB). ERS Congress 2013, Barcelona, P4136.
6. Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I,. Inhaled, dual-release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2)-a randomised, double-blind, placebo-controlled trial. Thorax 2013; 68: 812-817.
7. Serisier DJ, Martin M, McGuckin M, Lourie R, Chen A, Brain B, Dash P, Schlebusch S, Biga S, Bowler SD,. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis. The BLESS randomized controlled trial. JAMA 2013; 309: 1260-1267.
8. Serisier DJ, Martin M,. Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. Respir. Med. 2011; 105: 946-949.
9. Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, et al. Long-term azithromycin for indigenous children with non-cystic fibrosis bronchiectasis or chronic suppurative lung disease (bronchiectasis intervention study): a multicentre, double-blind, randomised controlled trial. Lancet Respir. Med. 2013; 1: 610-620.
10. Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin M, Serisier DJ,. Clinical measures of disease in non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013; 68: 731-737.
11. Serisier DJ,. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases. Lancet Respir. Med. 2013; 1: 262-274.
12. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J. Clin. Invest. 2011; 121: 3554-3563.
13. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, et al. The bronchiectasis severity index: an international derivation and validation study. Am. J. Respir. Crit. Care Med. 2013. (ePub ahead of print).